MLchartDataset catalogue

Risperidone formulation in rumenic acid

Term · Oncology and biomedicine · MLC-T-ONC-016555

An orally bioavailable capsule formulation containing the antipsychotic agent risperidone suspended in the lipid rumenic acid, with potential antineoplastic activity. Upon administration of VAL401, risperidone may, through an as of yet not elucidated mechanism of action, reduce cellular activity and tumor cell proliferation in multiple cancers.

Table 1. Record
IdentifierMLC-T-ONC-016555
FieldOncology and biomedicine
Synonymsrisperidone lipid formulation VAL401
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-016555",
  "term": "Risperidone formulation in rumenic acid",
  "field": "Oncology and biomedicine",
  "definition": "An orally bioavailable capsule formulation containing the antipsychotic agent risperidone suspended in the lipid rumenic acid, with potential antineoplastic activity. Upon administration of VAL401, risperidone may, through an as of yet not elucidated mechanism of action, reduce cellular activity and tumor cell proliferation in multiple cancers.",
  "synonyms": [
    "risperidone lipid formulation VAL401"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/risperidone-formulation-in-rumenic-acid/"
}

Record 14,508 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.